Sagimet Biosciences Inc.
SGMT
$10.55
$1.2713.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 17.64M | 18.03M | 17.84M | 17.78M | 17.43M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 52.63M | 48.74M | 56.89M | 64.32M | 66.89M |
| Operating Income | -52.63M | -48.74M | -56.89M | -64.32M | -66.89M |
| Income Before Tax | -47.08M | -43.51M | -51.04M | -57.67M | -59.38M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -47.08 | -43.51 | -51.04 | -57.67 | -59.38 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -47.08M | -43.51M | -51.04M | -57.67M | -59.38M |
| EBIT | -52.63M | -48.74M | -56.89M | -64.32M | -66.89M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -1.28 | -1.34 | -1.58 | -1.79 | -1.85 |
| Normalized Basic EPS | -0.80 | -0.84 | -0.99 | -1.12 | -1.15 |
| EPS Diluted | -1.28 | -1.34 | -1.58 | -1.79 | -1.85 |
| Normalized Diluted EPS | -0.80 | -0.84 | -0.99 | -1.12 | -1.15 |
| Average Basic Shares Outstanding | 150.66M | 129.74M | 129.38M | 129.05M | 128.73M |
| Average Diluted Shares Outstanding | 150.66M | 129.74M | 129.38M | 129.05M | 128.73M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |